All content for Alternatively Speaking is the property of KCSA Podcast Labs and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Sebastian Brunemeier, Longevity Biotech, Life Extension & the Next Era of Medicine
Alternatively Speaking
56 minutes 53 seconds
1 year ago
Sebastian Brunemeier, Longevity Biotech, Life Extension & the Next Era of Medicine
Welcome to Alternatively Speaking, a KCSA Podcast Labs production. In our debut season, we're diving into a revolutionary concept in health span, longevity, and healthcare.
Today, our hosts engage in a fascinating discussion with Sebastian Brunemeier, a true powerhouse in the longevity and regenerative medicine space. Sebastian is a biotech venture capitalist and company builder with a laser focus on extending human health span. As the co-founder and general partner of Healthspan Capital and the CEO and founder of ImmuneAgeBio, Sebastian is at the forefront of immune system rejuvenation research.
Over the past five years, he has co-founded four longevity biotech companies with a combined equity value exceeding $600 million. Sebastian's background includes roles as co-founder and chief investment officer at Cambrian Biopharma, co-founder and COO of Samsara Therapeutics, and principal at Apollo Health Ventures, the world's first and largest aging-focused venture capital fund managing $200 million in assets.
Sebastian’s influence extends beyond his business ventures, serving as a trustee of the British Society for Research on Aging, a mentor at the New York Academy of Sciences, and as an advisor to numerous organizations, including VitaDAO, Equator Therapeutics, and even McKinsey and Company.
Podcast Highlights:
Introduction to Sebastian Brunemeier (00:11): Overview of Sebastian's background and his various roles in the longevity biotech space.
The Longevity Biotech Landscape (02:36): Discussion of Sebastian's journey into longevity science and his mission to bring capital and talent into the field.
Healthspan Capital and Investment Strategy (27:48): Insights into Healthspan Capital's approach to investing in longevity biotech companies.
The Global Demographic Aging Crisis (23:25): Exploration of the "silver tsunami" and how longevity science aims to address this global challenge.
Cutting-Edge Research in Longevity (39:54): Discussion of promising studies in the longevity space, including blood plasma research and stem cell therapies.
The Political and Social Movement of Longevity (45:00): Introduction to the concept of startup cities and the Prospera project as hubs for longevity research and development.
Personal Longevity Practices (53:35): Sebastian's insights on personal health protocols and cautionary advice on experimental interventions.
This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications.
Special thanks to our Program Director, Shea Gunther, and Executive Producer, Maria Petsanas.
You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing AltSpeaking@kcsa.com. You can also connect with us via our social channels:
